Hill November 11, 2023
The Food and Drug Adminstration (FDA) approved the first vaccine for the mosquito-born illness chikungunya on Thursday, a key step in fighting the dangerous virus.
Chikungunya virus infects more than 300,000 people per year globally, the FDA said, mostly in the global south. The virus has recently become more prevalent in the north, however, leading to FDA approval of the new vaccine.
“Infection with chikungunya virus can lead to severe disease and prolonged health problems, particularly for older adults and individuals with underlying medical conditions,” Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.
“Today’s approval addresses an unmet medical need and is an important advancement in the prevention of a potentially...
Today's Sponsors
Today's Sponsor